quinoxalines has been researched along with anandamide in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bickler, PE; Bornheim, LM; Gray, AT; Hampson, AJ; Hansen, BM; Leonoudakis, DJ; Scanziani, M; Yost, CS | 1 |
| Gitlin, JM; Mitchell, JA; Stanford, SJ | 1 |
| Adler-Graschinsky, E; Mendizábal, VE; Orliac, ML | 1 |
| Fröhlich, K; Schäfer, F; Schmidt, W; Striggow, F; Striggow, V | 1 |
| Aguiar, JC; Guimarães, FS; Lisboa, SF; Magesto, AC; Resstel, LB | 1 |
5 other study(ies) available for quinoxalines and anandamide
| Article | Year |
|---|---|
Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission.
Topics: Animals; Arachidonic Acids; Brain; Calcium; Calcium Channel Blockers; Cannabinoids; Cerebellum; Cerebral Cortex; Dronabinol; Endocannabinoids; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Membrane Potentials; N-Methylaspartate; Neurons; Oocytes; Pertussis Toxin; Picrotoxin; Polyunsaturated Alkamides; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission; Virulence Factors, Bordetella; Wasp Venoms; Xenopus laevis | 1998 |
Identification of two distinct vasodilator pathways activated by ATP in the mesenteric bed of the rat.
Topics: Adenine; Adenosine; Adenosine Triphosphate; Animals; Arachidonic Acids; Capsaicin; Dose-Response Relationship, Drug; Endocannabinoids; Endothelium, Vascular; Enzyme Inhibitors; Guanylate Cyclase; Histamine; In Vitro Techniques; Male; Mesenteric Arteries; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxadiazoles; Piperidines; Polyunsaturated Alkamides; Potassium Chloride; Pyrazoles; Pyrilamine; Quinoxalines; Rats; Rats, Wistar; Rimonabant; Signal Transduction; Stereoisomerism; Theophylline; Vasodilation | 2001 |
Long-term inhibition of nitric oxide synthase potentiates effects of anandamide in the rat mesenteric bed.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Capsaicin; Dose-Response Relationship, Drug; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Guanylate Cyclase; In Vitro Techniques; Indoles; Male; Mesenteric Arteries; Morpholines; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Norepinephrine; Oxadiazoles; Phenylmethylsulfonyl Fluoride; Polyunsaturated Alkamides; Pyrazoles; Quinoxalines; Rats; Rats, Wistar; Time Factors; Vasoconstriction; Vasoconstrictor Agents | 2001 |
Cannabinoid receptor subtypes 1 and 2 mediate long-lasting neuroprotection and improve motor behavior deficits after transient focal cerebral ischemia.
Topics: Animals; Arachidonic Acids; Brain; Brain Infarction; Cannabinoids; Disease Models, Animal; Dose-Response Relationship, Drug; Ectodysplasins; Endocannabinoids; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Indans; Infarction, Middle Cerebral Artery; Leukocyte Common Antigens; Male; Movement Disorders; Neuroprotective Agents; Polyunsaturated Alkamides; Psychomotor Performance; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Sulfonic Acids; Time Factors | 2012 |
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Topics: Animals; Anxiety; Apomorphine; Arachidonic Acids; Bicuculline; Cannabinoid Receptor Agonists; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; GABA-A Receptor Antagonists; Male; Maze Learning; Nitric Oxide Synthase; Oxadiazoles; Periaqueductal Gray; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Quinoxalines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2013 |